Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of HQL
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Tekla Life Sciences Investors stock price ended at $14.29 on Tuesday, after gaining 0.210%.
(Updated on Jul 02, 2024)

Buy candidate since Jun 21, 2024 Gain 3.85% PDF

The Tekla Life Sciences Investors stock price gained 0.210% on the last trading day (Tuesday, 2nd Jul 2024), rising from $14.26 to $14.29. During the last trading day the stock fluctuated 0.98% from a day low at $14.24 to a day high of $14.38. The price has risen in 7 of the last 10 days and is up by 3.55% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 6 thousand more shares were traded than the day before. In total, 89 thousand shares were bought and sold for approximately $1.27 million.

The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 7.87% during the next 3 months and, with a 90% probability hold a price between $14.51 and $15.98 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

HQL Signals & Forecast

Mostly positive signals in the chart today. The Tekla Life Sciences Investors stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $14.19 and $13.82. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, May 29, 2024, and so far it has risen 9.50%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Tekla Life Sciences Investors has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Support, Risk & Stop-loss for Tekla Life Sciences Investors stock

Tekla Life Sciences Investors finds support from accumulated volume at $14.26 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.140 between high and low, or 0.98%. For the last week the stock has had daily average volatility of 0.786%.

Our recommended stop-loss: $13.78 (-3.56%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 31 days ago.)

Trading Expectations (HQL) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect Tekla Life Sciences Investors to open at $14.30, and during the day (based on 14 day Average True Range), to move between $14.13 and $14.45, which gives a possible trading interval of +/-$0.161 (+/-1.13%) up or down from last closing price. If Tekla Life Sciences Investors takes out the full calculated possible swing range there will be an estimated 2.26% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $14.26, some $0.0300 (0.21%) from the current price of $14.29, our system finds the risk reward attractive.

Is Tekla Life Sciences Investors stock A Buy?

Tekla Life Sciences Investors holds several positive signals and is within a weak rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

Current score: 7.146 Strong Buy Candidate Unchanged

Predicted Opening Price for Tekla Life Sciences Investors of Wednesday, July 3, 2024

Fair opening price July 3, 2024 Current price
$14.30 ( 0.0933%) $14.29

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for HQL

Fibonacci Support & Resistance Levels

Level Price
R3 14.44 1.07%
R2 14.39 0.699%
R1 14.36 0.468%
Price 14.29
S1 14.25 -0.281%
S2 14.22 -0.512%
S3 14.16 -0.89%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 14.29
S1 14.26 -0.210%
S2 14.17 -0.84%
S3 12.79 -10.50%

HQL Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 09, 2024 May 22, 2024 Jun 28, 2024 $0.480 3.39%
2 Feb 21, 2024 Feb 21, 2024 Mar 28, 2024 $0.390 2.86%
3 Nov 09, 2023 Nov 21, 2023 Jan 10, 2024 $0.300 2.09%
4 Aug 15, 2023 Aug 24, 2023 Sep 29, 2023 $0.320 2.57%
5 May 15, 2023 May 24, 2023 Jun 30, 2023 $0.320 2.36%

FAQ

What is the symbol for Tekla Life Sciences Investors Stock and on which exchange is it traded?
The symbol for Tekla Life Sciences Investors is HQL and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Tekla Life Sciences Investors Stock?
Tekla Life Sciences Investors holds several positive signals and is within a weak rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

How to buy Tekla Life Sciences Investors Stock?
Tekla Life Sciences Investors Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Tekla Life Sciences Investors Stock.

What's the current price of Tekla Life Sciences Investors Stock?
As of the end of day on the Jul 02, 2024, the price of an Tekla Life Sciences Investors (HQL) share was $14.29.

What is the 52-week high and low for Tekla Life Sciences Investors Stock?
The 52-week high for Tekla Life Sciences Investors Stock is $14.38 and the 52-week low is $11.34.

What is the market capitalization of Tekla Life Sciences Investors Stock?
As of the Jul 02, 2024, the market capitalization of Tekla Life Sciences Investors is 390.018M.

When is the next earnings date for Tekla Life Sciences Investors?
The upcoming earnings date for Tekla Life Sciences Investors is Aug 06, 2024.
Click to get the best stock tips daily for free!

About Tekla Life Sciences Investors

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries,... HQL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT